KWIN
Price
$25.97Alerts
Change
-$0.02 (-0.08%)
Updated
Nov 11, 04:59 PM (EDT)
Net Assets
63.48M
Intraday BUY SELL Signals
ORLY
Price
$90.54Alerts
Change
+$1.15 (+1.29%)
Updated
Nov 11 closing price
Capitalization
72.72B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KWIN vs ORLY

KWIN vs ORLY Comparison Chart in %
View a ticker or compare two or three
VS
KWIN vs. ORLY commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KWIN is a Buy and ORLY is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for KWIN with price predictions
Nov 10, 2026

KWIN's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for KWIN turned positive on November 09, 2026. Looking at past instances where KWIN's MACD turned positive, the stock continued to rise in 6 of 16 cases over the following month. The odds of a continued upward trend are 38%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on KWIN as a result. In 11 of 31 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 35%.

Following a +0.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where KWIN advanced for three days, in 12 of 47 cases, the price rose further within the following month. The odds of a continued upward trend are 26%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KWIN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 8%.

KWIN broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
a Summary for ORLY with price predictions
Nov 10, 2026

ORLY in upward trend: 10-day moving average broke above 50-day moving average on October 21, 2026

The 10-day moving average for ORLY crossed bullishly above the 50-day moving average on October 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ORLY moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +2.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where ORLY advanced for three days, in 208 of 383 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.

The Aroon Indicator entered an Uptrend today. In 129 of 260 cases where ORLY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 50%.

Bearish Trend Analysis

The 10-day RSI Indicator for ORLY moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 19 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 46%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 25 of 60 cases where ORLY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 42%.

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ORLY as a result. In 41 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.

The Moving Average Convergence Divergence Histogram (MACD) for ORLY turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 23 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORLY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 45%.

ORLY broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ORLY's P/B Ratio (-39.612) is very low in comparison to the industry average of (0.781). P/E Ratio (28.446) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (1.620) is also within normal values, averaging (1.494). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (3.798) is also within normal values, averaging (49.456).

The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. ORLY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
ORLY: Fundamental Ratings
ORLY
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
20
SMR RATING
1..100
3
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
67
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KWINORLY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
46%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
18%
Bearish Trend 2 days ago
42%
Momentum
ODDS (%)
Bullish Trend 2 days ago
35%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bullish Trend 2 days ago
38%
Bearish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
46%
Bearish Trend 2 days ago
47%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
49%
Bullish Trend 2 days ago
53%
Advances
ODDS (%)
Bullish Trend 2 days ago
26%
Bullish Trend 10 days ago
54%
Declines
ODDS (%)
Bearish Trend 27 days ago
8%
Bearish Trend 2 days ago
45%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
38%
Bearish Trend 2 days ago
48%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement

KWIN and

Correlation & Price change

A.I.dvisor tells us that KWIN and ORLY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KWIN and ORLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KWIN
1D Price
Change %
KWIN100%
+0.15%
ORLY - KWIN
16%
Poorly correlated
-0.45%
ISRG - KWIN
13%
Poorly correlated
-2.28%
VRTX - KWIN
10%
Poorly correlated
-0.54%
BSX - KWIN
9%
Poorly correlated
+1.54%
AZO - KWIN
8%
Poorly correlated
-1.04%
More

ORLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORLY has been loosely correlated with AAP. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ORLY jumps, then AAP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORLY
1D Price
Change %
ORLY100%
-0.45%
AAP - ORLY
52%
Loosely correlated
-0.13%
CPRT - ORLY
45%
Loosely correlated
-0.46%
LKQ - ORLY
37%
Loosely correlated
-1.08%
MUSA - ORLY
36%
Loosely correlated
+1.89%
KMX - ORLY
36%
Loosely correlated
+0.15%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTHR588.616.15
+1.06%
United Therapeutics Corp
ACHC38.640.03
+0.08%
Acadia Healthcare Company
ULH29.33-0.28
-0.95%
Universal Logistics Holdings
NGEN1.33-0.06
-4.66%
NervGen Pharma Corp.
BLRX1.47-0.23
-13.53%
BioLineRx Ltd